FENNEC PHARMACEUTICALS INC. Net Cash Provided by (Used in) Investing Activities, Continuing Operations
FENNEC PHARMACEUTICALS INC. (FENC) reported Net Cash Provided by (Used in) Investing Activities, Continuing Operations of $0 for the 3-month period ending 2017-03-31, per its 10-Q filed 2017-05-12.
Discontinued › Cash Flow › Investing Activities
us-gaap:NetCashProvidedByUsedInInvestingActivitiesContinuingOperations · last filed 2017-05-12
- FENNEC PHARMACEUTICALS INC. net cash provided by (used in) investing activities, continuing operations for the quarter ending 2017-03-31 was $0.00.
- FENNEC PHARMACEUTICALS INC. net cash provided by (used in) investing activities, continuing operations for the quarter ending 2016-12-31 was $0.00.
- FENNEC PHARMACEUTICALS INC. net cash provided by (used in) investing activities, continuing operations for the quarter ending 2016-09-30 was $0.00.
- FENNEC PHARMACEUTICALS INC. net cash provided by (used in) investing activities, continuing operations for the quarter ending 2016-06-30 was $0.00.
- FENNEC PHARMACEUTICALS INC. net cash provided by (used in) investing activities, continuing operations for fiscal 2016 was $0.00.
- FENNEC PHARMACEUTICALS INC. net cash provided by (used in) investing activities, continuing operations for fiscal 2015 was $0.00.
- FENNEC PHARMACEUTICALS INC. net cash provided by (used in) investing activities, continuing operations for fiscal 2014 was $0.00.
| Period end | Net Cash Provided by (Used in) Investing Activities, Continuing Operations 3 month | Net Cash Provided by (Used in) Investing Activities, Continuing Operations 6 month | Net Cash Provided by (Used in) Investing Activities, Continuing Operations 9 month | Net Cash Provided by (Used in) Investing Activities, Continuing Operations 12 month |
|---|---|---|---|---|
| 2017-03-31 | $0.00 10-Q · filed 2017-05-12 | $0.00 derived: sum of 2 quarters · filed 2017-05-12 | $0.00 derived: sum of 3 quarters · filed 2017-05-12 | $0.00 derived: sum of 4 quarters · filed 2017-05-12 |
| 2016-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-29 | $0.00 derived: sum of 2 quarters · filed 2017-03-29 | $0.00 derived: sum of 3 quarters · filed 2017-03-29 | $0.00 10-K · filed 2017-03-29 |
| 2016-09-30 | $0.00 10-Q · filed 2016-11-14 | $0.00 derived: sum of 2 quarters · filed 2016-11-14 | $0.00 10-Q · filed 2016-11-14 | $0.00 derived: sum of 4 quarters · filed 2017-05-12 |
| 2016-06-30 | $0.00 10-Q · filed 2016-08-12 | $0.00 10-Q · filed 2016-08-12 | $0.00 derived: sum of 3 quarters · filed 2017-05-12 | $0.00 derived: sum of 4 quarters · filed 2017-05-12 |
| 2016-03-31 | $0.00 10-Q · filed 2017-05-12 | $0.00 derived: sum of 2 quarters · filed 2017-05-12 | $0.00 derived: sum of 3 quarters · filed 2017-05-12 | $0.00 derived: sum of 4 quarters · filed 2017-05-12 |
| 2015-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-29 | $0.00 derived: sum of 2 quarters · filed 2017-03-29 | $0.00 derived: sum of 3 quarters · filed 2017-03-29 | $0.00 10-K · filed 2017-03-29 |
| 2015-09-30 | $0.00 10-Q · filed 2016-11-14 | $0.00 derived: sum of 2 quarters · filed 2016-11-14 | $0.00 10-Q · filed 2016-11-14 | |
| 2015-06-30 | $0.00 10-Q · filed 2016-08-12 | $0.00 10-Q · filed 2016-08-12 | ||
| 2015-03-31 | $0.00 10-Q · filed 2016-05-12 | |||
| 2014-12-31 | $0.00 10-K · filed 2016-03-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| C4 Therapeutics, Inc. (CCCC) | United States | $0.373B | -5.65 |
| Artiva Biotherapeutics, Inc. (ARTV) | United States | $0.367B | |
| Cabaletta Bio, Inc. (CABA) | United States | $0.365B | -2.81 |
| AGENUS INC (AGEN) | United States | $0.383B | 1.41 |
| Surrozen, Inc./DE (SRZN) | United States | $0.395B | |
| Zura Bio Ltd (ZURA) | $0.398B | -6.56 | |
| Ocugen, Inc. (OCGN) | United States | $0.343B | -6.34 |
| Scribe Therapeutics, Inc. (SCTX) | United States | $0.410B | |
| Editas Medicine, Inc. (EDIT) | United States | $0.424B | -4.29 |
| Kyverna Therapeutics, Inc. (KYTX) | United States | $0.434B | -3.60 |